Clinical Trial: A Study for HSK47388 in Participants With Ulcerative Colitis

U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07335055) titled 'A Study for HSK47388 in Participants With Ulcerative Colitis' on Jan. 04.

Brief Summary: The purpose of this protocol is to evaluate the efficacy and safety of HSK47388 as therapy in participants with moderately to severely active ulcerative colitis .

Study Start Date: Jan. 29

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis (UC)

Intervention: DRUG: HSK47388

Participants will be randomized to receive HSK47388, orally starting at Week 0 . At Week-12, all participants will be evaluated for clinical response and responders will enter the maintenance study.

DRUG: Placebo

Participants will be randomized to receive Placeb...